ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP11

Exercise as a Supportive Treatment for My Ankylosing Spondylitis

Sara King-Dowling, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), exercise

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Patients with autoimmune rheumatic diseases (ARDs) are often caught in a paradox as they experience mobility challenges, but long periods of immobility cause increased stiffness and pain. I have been living with symptoms of Ankylosing Spondylitis (AS) for eleven years. It took almost 4 years from onset of symptoms to my diagnosis. Before I received a diagnosis, I tried to manage my symptoms on a regimen of non-steroidal anti-inflammatory drugs (NSAIDS). I had always been an active person, but the joint pain and stiffness that started when I was twenty-two years old made it almost impossible for me to participate in the activities and sports I enjoyed. I had completely lost my identity as an athlete.

Intervention: When I received my diagnosis at the age of twenty-six, I was started on a biologic treatment for my AS. I was finally able to sleep through the night and I no longer had to worry about leaving the house without my NSAIDS. As my body began to respond to treatment, I slowly began to regain the mobility I had lost and was able to engage in more physical activity. I joined a gym for the first time and committed to going to morning fitness classes to improve my cardiovascular fitness and muscular strength and extend my range of motion.

Maintenance: With my combination of adhering to my treatment of a monthly biologic injection and daily morning exercise routine, I have felt virtually in remission for the last 7 years. Missing even a day or two at the gym can aggravate my stiffness and increase my pain. Committing to a structured exercise plan is what has kept my AS symptoms at bay. This has increased my range of motion and muscle strength as well as helped my mental health. The cumulative effects of this have extended to multiple facets of my well-being making me less stressed, more patient and overall happier.

Quality of Life: I have a newfound appreciation for my body: what it has been through and what it has been able to achieve. Although I know that my biologics might stop working as effectively and I may start to experience flares again, I must trust that as long as I keep moving, I will win the battle against AS.

Supporting image 1

Figure 1: Resisting the Vicious Cycle: My thought process to motivate me to move

Supporting image 2

Figure 2: My Daily Exercise Minutes over the past year according to my Apple Watch

Supporting image 3

Figure 3: Me, exercising at the gym


Disclosures: S. King-Dowling, None.

To cite this abstract in AMA style:

King-Dowling S. Exercise as a Supportive Treatment for My Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/exercise-as-a-supportive-treatment-for-my-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exercise-as-a-supportive-treatment-for-my-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology